Myeloma: FDA Advisers Greenlight Early CAR-T

An FDA advisory panel endorsed earlier use of CAR-T therapies to treat multiple myeloma but emphasized the importance of informing patients about potential risks associated with these treatments.
MDedge News

source https://www.medscape.com/s/viewarticle/myeloma-fda-advisers-greenlight-early-car-t-2024a100058w?src=rss